Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hong

Showing results (81-90 of 272) with videos related to

Pageof 28
Sort By:
Cancer|August 26, 2010
Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experienceChristos Vaklavas, Apostolia-Maria Tsimberidou, Sijin Wen, et al.
Cancer Treatment Reviews|May 7, 2018
Untying the gordion knot of targeting MET in cancerKanwal Raghav, Ann Marie Bailey, Jonathan M Loree, et al.
Insects|April 27, 2023
Novel Sophoridine Derivatives as Potential Larvicidal Agents against <i>Aedes albopictus</i>: Synthesis, Biological Evaluation, Acetylcholinesterase Inhibition, and Morphological StudySong Ang, Nana Cao, Wende Zheng, et al.
BMC Cancer|April 18, 2015
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistanceJennifer Wheler, Roman Yelensky, Gerald Falchook, et al.
Korean Circulation Journal|December 10, 2025
Real-World Efficacy of Tafamidis in Korean ATTR-CM Patients: A Retrospective Observational Strain AnalysisHeayoung Shin, Kina Jeon, Darae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2012
Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experienceJennifer Wheler, Apostolia M Tsimberidou, David Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomasDavid J Stewart, Jean-Pierre Issa, Razelle Kurzrock, et al.
Future Oncology (London, England)|March 31, 2023
Plain language summary of the development of tepotinib: a treatment for a subtype of non-small cell lung cancer called <i>MET</i> exon 14 skippingJohn Hallick, Anne-Marie Baird, Gerald Falchook, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|March 26, 2020
A novel fluorescent probe for the detection of AmpC beta-lactamase and the application in screening beta-lactamase inhibitorsPan Yu, Jia-Ning Yang, Jin-Wu Yan, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitorLan Yu, Vasu Tumati, Shu-Fen Tseng, et al.
Pageof 28

Showing results (81-90 of 272) with videos related to

Sort By:
Pageof 28
Cancer|August 26, 2010
Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experienceChristos Vaklavas, Apostolia-Maria Tsimberidou, Sijin Wen, et al.
Cancer Treatment Reviews|May 7, 2018
Untying the gordion knot of targeting MET in cancerKanwal Raghav, Ann Marie Bailey, Jonathan M Loree, et al.
Insects|April 27, 2023
Novel Sophoridine Derivatives as Potential Larvicidal Agents against <i>Aedes albopictus</i>: Synthesis, Biological Evaluation, Acetylcholinesterase Inhibition, and Morphological StudySong Ang, Nana Cao, Wende Zheng, et al.
BMC Cancer|April 18, 2015
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistanceJennifer Wheler, Roman Yelensky, Gerald Falchook, et al.
Korean Circulation Journal|December 10, 2025
Real-World Efficacy of Tafamidis in Korean ATTR-CM Patients: A Retrospective Observational Strain AnalysisHeayoung Shin, Kina Jeon, Darae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2012
Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experienceJennifer Wheler, Apostolia M Tsimberidou, David Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomasDavid J Stewart, Jean-Pierre Issa, Razelle Kurzrock, et al.
Future Oncology (London, England)|March 31, 2023
Plain language summary of the development of tepotinib: a treatment for a subtype of non-small cell lung cancer called <i>MET</i> exon 14 skippingJohn Hallick, Anne-Marie Baird, Gerald Falchook, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|March 26, 2020
A novel fluorescent probe for the detection of AmpC beta-lactamase and the application in screening beta-lactamase inhibitorsPan Yu, Jia-Ning Yang, Jin-Wu Yan, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitorLan Yu, Vasu Tumati, Shu-Fen Tseng, et al.
Pageof 28